Annual Accounts Payable
$7.83 M
+$7.35 M+1521.12%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual accounts payable is $7.83 million, with the most recent change of +$7.35 million (+1521.12%) on December 31, 2023.
- During the last 3 years, IRWD annual accounts payable has risen by +$7.17 million (+1084.57%).
- IRWD annual accounts payable is now -63.96% below its all-time high of $21.73 million, reached on December 31, 2012.
Performance
IRWD Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.24 M
+$9000.00+0.28%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly accounts payable is $3.24 million, with the most recent change of +$9000.00 (+0.28%) on September 30, 2024.
- Over the past year, IRWD quarterly accounts payable has stayed the same.
- IRWD quarterly accounts payable is now -89.12% below its all-time high of $29.74 million, reached on March 31, 2013.
Performance
IRWD Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IRWD Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1521.1% | 0.0% |
| 3 y3 years | +1084.6% | +246.1% |
| 5 y5 years | -47.4% | +246.1% |
IRWD Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1521.1% | -58.7% | +2642.4% |
| 5 y | 5-year | at high | +1521.1% | -58.7% | +2642.4% |
| alltime | all time | -64.0% | +1521.1% | -89.1% | +2642.4% |
Ironwood Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.24 M(+0.3%) |
| Jun 2024 | - | $3.23 M(-48.1%) |
| Mar 2024 | - | $6.22 M(-20.5%) |
| Dec 2023 | $7.83 M(+1521.1%) | $7.83 M(+66.7%) |
| Sep 2023 | - | $4.70 M(+34.0%) |
| Jun 2023 | - | $3.50 M(+2870.3%) |
| Mar 2023 | - | $118.00 K(-75.6%) |
| Dec 2022 | $483.00 K(-48.3%) | $483.00 K(-39.2%) |
| Sep 2022 | - | $795.00 K(+150.8%) |
| Jun 2022 | - | $317.00 K(-40.4%) |
| Mar 2022 | - | $532.00 K(-43.1%) |
| Dec 2021 | $935.00 K(+41.5%) | $935.00 K(+125.8%) |
| Sep 2021 | - | $414.00 K(-11.2%) |
| Jun 2021 | - | $466.00 K(-44.7%) |
| Mar 2021 | - | $842.00 K(+27.4%) |
| Dec 2020 | $661.00 K(-88.0%) | $661.00 K(-72.1%) |
| Sep 2020 | - | $2.37 M(-16.9%) |
| Jun 2020 | - | $2.85 M(-25.6%) |
| Mar 2020 | - | $3.84 M(-30.0%) |
| Dec 2019 | $5.49 M(-63.2%) | $5.49 M(-10.0%) |
| Sep 2019 | - | $6.10 M(-38.5%) |
| Jun 2019 | - | $9.91 M(-11.6%) |
| Mar 2019 | - | $11.20 M(-24.8%) |
| Dec 2018 | $14.89 M(-6.7%) | $14.89 M(+59.6%) |
| Sep 2018 | - | $9.33 M(-60.8%) |
| Jun 2018 | - | $23.79 M(+104.9%) |
| Mar 2018 | - | $11.61 M(-27.3%) |
| Dec 2017 | $15.96 M(-9.9%) | $15.96 M(-8.9%) |
| Sep 2017 | - | $17.51 M(-17.3%) |
| Jun 2017 | - | $21.19 M(+3.0%) |
| Mar 2017 | - | $20.58 M(+16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $17.70 M(+106.1%) | $17.70 M(-10.4%) |
| Sep 2016 | - | $19.75 M(+119.5%) |
| Jun 2016 | - | $9.00 M(+89.8%) |
| Mar 2016 | - | $4.74 M(-44.8%) |
| Dec 2015 | $8.59 M(-12.0%) | $8.59 M(+45.5%) |
| Sep 2015 | - | $5.90 M(-11.2%) |
| Jun 2015 | - | $6.65 M(+27.2%) |
| Mar 2015 | - | $5.23 M(-46.5%) |
| Dec 2014 | $9.76 M(-4.2%) | $9.76 M(+59.8%) |
| Sep 2014 | - | $6.11 M(+79.8%) |
| Jun 2014 | - | $3.40 M(-30.1%) |
| Mar 2014 | - | $4.86 M(-52.3%) |
| Dec 2013 | $10.19 M(-53.1%) | $10.19 M(+23.9%) |
| Sep 2013 | - | $8.22 M(-40.6%) |
| Jun 2013 | - | $13.84 M(-53.5%) |
| Mar 2013 | - | $29.74 M(+36.9%) |
| Dec 2012 | $21.73 M(+237.6%) | $21.73 M(+353.3%) |
| Sep 2012 | - | $4.79 M(-54.9%) |
| Jun 2012 | - | $10.63 M(+235.1%) |
| Mar 2012 | - | $3.17 M(-50.7%) |
| Dec 2011 | $6.44 M(+49.6%) | $6.44 M(+169.3%) |
| Sep 2011 | - | $2.39 M(-63.3%) |
| Jun 2011 | - | $6.51 M(+123.0%) |
| Mar 2011 | - | $2.92 M(-32.2%) |
| Dec 2010 | $4.30 M(-9.5%) | $4.30 M(-17.3%) |
| Jun 2010 | - | $5.20 M(+1.7%) |
| Mar 2010 | - | $5.12 M(+7.6%) |
| Dec 2009 | $4.75 M(+27.3%) | $4.75 M(-26.1%) |
| Sep 2009 | - | $6.43 M(+72.3%) |
| Dec 2008 | $3.73 M(-33.1%) | $3.73 M |
| Dec 2007 | $5.58 M | - |
FAQ
- What is Ironwood Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual accounts payable year-on-year change?
- What is Ironwood Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly accounts payable year-on-year change?
What is Ironwood Pharmaceuticals annual accounts payable?
The current annual accounts payable of IRWD is $7.83 M
What is the all time high annual accounts payable for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual accounts payable is $21.73 M
What is Ironwood Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, IRWD annual accounts payable has changed by +$7.35 M (+1521.12%)
What is Ironwood Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of IRWD is $3.24 M
What is the all time high quarterly accounts payable for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly accounts payable is $29.74 M
What is Ironwood Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, IRWD quarterly accounts payable has changed by $0.00 (0.00%)